These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21180781)

  • 21. Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure.
    Testani JM; Brisco MA; Tang WH; Kimmel SE; Tiku-Owens A; Forfia PR; Coca SG
    J Card Fail; 2013 May; 19(5):295-302. PubMed ID: 23663810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of the DIG trial.
    Collins JF; Egan D; Yusuf S; Garg R; Williford WO; Geller N;
    Control Clin Trials; 2003 Dec; 24(6 Suppl):269S-276S. PubMed ID: 14643073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal digoxin concentrations for patients with heart failure.
    Carbonin P; Zuccalà G
    JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771104
    [No Abstract]   [Full Text] [Related]  

  • 24. Digoxin may reduce the mortality rates in patients with congestive heart failure.
    Wang L; Song S
    Med Hypotheses; 2005; 64(1):124-6. PubMed ID: 15533628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
    Gheorghiade M; Patel K; Filippatos G; Anker SD; van Veldhuisen DJ; Cleland JG; Metra M; Aban IB; Greene SJ; Adams KF; McMurray JJ; Ahmed A
    Eur J Heart Fail; 2013 May; 15(5):551-9. PubMed ID: 23355060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of inotropic support of the failing heart.
    Knight DH
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):879-904. PubMed ID: 1949498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digoxin's effect on mortality and hospitalization in heart failure: implications of the DIG study. Digitalis Investigation Group.
    Hobbs RE
    Cleve Clin J Med; 1997 May; 64(5):234-7. PubMed ID: 9149472
    [No Abstract]   [Full Text] [Related]  

  • 28. 200+ years of a misunderstood drug for treating chronic heart failure: digoxin, why and how should we continue using it?
    Hothi SS; Chinnappa S; Tan LB
    Int J Cardiol; 2013 Sep; 168(2):645-7. PubMed ID: 22608274
    [No Abstract]   [Full Text] [Related]  

  • 29. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure.
    Mathew J; Hunsberger S; Fleg J; Mc Sherry F; Williford W; Yusuf S
    Chest; 2000 Oct; 118(4):914-22. PubMed ID: 11035656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
    Nagai Y; Hayakawa T; Abe T; Nomura G
    Diabetes Care; 2000 Nov; 23(11):1703. PubMed ID: 11092296
    [No Abstract]   [Full Text] [Related]  

  • 31. Digoxin in heart failure.
    Chadwell M; French L
    J Fam Pract; 1997 May; 44(5):442. PubMed ID: 9152256
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
    Guzman M; Gomez R; Romero SP; Aranda R; Andrey JL; Pedrosa MJ; Egido J; Gomez F
    Int J Clin Pract; 2018 Nov; 72(11):e13217. PubMed ID: 30248211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Digitalis, a drug to be scrapped?].
    Cosmi F; Tarquini B; Mariottoni B; Cosmi D
    G Ital Cardiol (Rome); 2017 Feb; 18(2):121-128. PubMed ID: 28398365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative trial of digoxin and digitoxin in the treatment of congestive heart failure.
    Bussey HI; Hawkins DW; Gaspard JJ; Walsh RA
    Pharmacotherapy; 1988; 8(4):235-40. PubMed ID: 3057476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin in patients with heart failure.
    Soto J; Avendaño C; Vilchez FG
    N Engl J Med; 1997 Jul; 337(2):129; author reply 130-1. PubMed ID: 9221337
    [No Abstract]   [Full Text] [Related]  

  • 37. Digoxin for the treatment of heart failure.
    Hallberg P; Michaëlsson K; Melhus H
    N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587575
    [No Abstract]   [Full Text] [Related]  

  • 38. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure.
    Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482
    [No Abstract]   [Full Text] [Related]  

  • 39. Digoxin--new perspective on an old drug.
    Eichhorn EJ; Gheorghiade M
    N Engl J Med; 2002 Oct; 347(18):1394-5. PubMed ID: 12409540
    [No Abstract]   [Full Text] [Related]  

  • 40. Digoxin in heart failure.
    Spencer AP
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):447-52. PubMed ID: 14717389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.